Market

Goldman Sachs downgrades Straumann stock to Neutral on slower growth outlook

Goldman Sachs downgrades Straumann stock to Neutral on slower growth outlook
Read More

Related Posts

Enanta Pharma CBO Luu sells $19,836 in stock

Enanta Pharma CBO Luu sells $19,836 in stock

Two of Brazil’s nine central bank seats likely to be unfilled at January meeting, sources say

Two of Brazil’s nine central bank seats likely to be un...

Enanta Pharma chief medical officer sells $11k in stock

Enanta Pharma chief medical officer sells $11k in stock

Here’s how the best investors protect their money from market bubbles and FOMO

Here’s how the best investors protect their money from ...

What does Netflix’s offer to buy HBO Max mean for you?

What does Netflix’s offer to buy HBO Max mean for you?

BioLife Solutions (BLFS) CFO Wichterman sells $771,600 in stock

BioLife Solutions (BLFS) CFO Wichterman sells $771,600 ...